Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2011
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 21 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 21 Dec 2011 Actual patient number (74) added as reported by ClinicalTrials.gov.
- 21 Dec 2011 Actual initiation date (Jul 2011) added as reported by ClinicalTrials.gov.